Cytosorbents

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytosorbents and other ETFs, options, and stocks.

About CTSO

CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb.

CEO

Phillip P. Chan

CEOPhillip P. Chan

Employees

149

Employees149

Headquarters

Princeton, New Jersey

HeadquartersPrinceton, New Jersey

Founded

1997

Founded1997

Employees

149

Employees149

CTSO Key Statistics

Market cap

58.00M

Market cap58.00M

Price-Earnings ratio

-4.90

Price-Earnings ratio-4.90

Dividend yield

—

Dividend yield—

Average volume

165.70K

Average volume165.70K

High today

$0.9303

High today$0.9303

Low today

$0.90

Low today$0.90

Open price

$0.90

Open price$0.90

Volume

97.86K

Volume97.86K

52 Week high

$1.61

52 Week high$1.61

52 Week low

$0.7101

52 Week low$0.7101

CTSO News

TipRanks 1d

CytoSorbents provides update of its appeal with FDA regarding DrugSorb-ATR

CytoSorbents (CTSO) updates the regulatory status of its appeal with the FDA for De Novo market authorization of DrugSorb-ATR. On August 14 the Company received...

People also own

Based on the portfolios of people who own CTSO. This list is generated using Robinhood data, and it’s not a recommendation.